Search Results - "DUPRIEZ, B"

Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the international working group for myelofibrosis research and treatment by Barosi, G, Mesa, R A, Thiele, J, Cervantes, F, Campbell, P J, Verstovsek, S, Dupriez, B, Levine, R L, Passamonti, F, Gotlib, J, Reilly, J T, Vannucchi, A M, Hanson, C A, Solberg, L A, Orazi, A, Tefferi, A

Get full text

What are RBC-transfusion-dependence and -independence? by Gale, R.P, Barosi, G, Barbui, T, Cervantes, F, Dohner, K, Dupriez, B, Gupta, V, Harrison, C, Hoffman, R, Kiladjian, J.-J, Mesa, R, Mc Mullin, M.F, Passamonti, F, Ribrag, V, Roboz, G, Saglio, G, Vannucchi, A, Verstovsek, S

“…Abstract The term RBC-transfusion-dependence is widely-used by hematologists to describe a condition of severe anemia typically arising when erythropoiesis is…”
Get full text

Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol by Diviné, M., Casassus, P., Koscielny, S., Bosq, J., Sebban, C., Le Maignan, C., Stamattoulas, A., Dupriez, B., Raphaël, M., Pico, J.-L., Ribrag, V.

“…Background: We conducted a phase II study to evaluate in 72 adult patients the efficacy of the intensive LMB chemotherapy regimen, previously reported by the…”
Get full text

Low-Dose Thalidomide Ameliorates Cytopenias and Splenomegaly in Myelofibrosis With Myeloid Metaplasia: A Phase II Trial by MARCHETTI, Monia, BAROSI, Giovanni, GROSSI, Alberto, LE BOUSSE-KERDILES, Marie Caroline, CAENAZZO, Andrea, PECCI, Alessandro, FALCONE, Antonietta, BROCCIA, Giorgio, BENDOTTI, Cesarina, BAUDUER, Fredric, BUCCISANO, Francesco, DUPRIEZ, Brigitte, BALESTRI, Francesca, VIARENGO, Gianluca, GENTILI, Sara, BARULLI, Sara, DEMORY, Jean-Loup, ILARIUCCI, Fiorella, VOLPE, Antonio, BORDESSOULE, Dominique

“…A phase II dose-escalation trial was conducted to ascertain low-dose thalidomide safety and response in patients with advanced myelofibrosis with myeloid…”
Get full text

High-dose imatinib mesylate combined with vincristine and dexamethasone (DIV regimen) as induction therapy in patients with resistant Philadelphia-positive acute lymphoblastic leukemia and lymphoid blast crisis of chronic myeloid leukemia by REA, D, LEGROS, L, STEPHANE, D, ROYER, B, VIGIER, M, OJEDA-URIBE, M, RECHER, C, DOMBRET, H, HUGUET, F, ROUSSELOT, P, RAFFOUX, E, THOMAS, X, TURLURE, P, MAURY, S, DUPRIEZ, B, PIGNEUX, A, CHOUFI, B, REMAN, O

“…Imatinib combined with high-dose chemotherapy is now becoming the gold standard for treatment of Philadelphia chromosome-positive acute leukemias. However, in…”
Get full text

Response criteria for myelofibrosis with myeloid metaplasia: results of an initiative of the European Myelofibrosis Network (EUMNET) by Barosi, Giovanni, Bordessoule, Dominique, Briere, Jean, Cervantes, Francisco, Demory, Jean-Loup, Dupriez, Brigitte, Gisslinger, Heinz, Griesshammer, Martin, Hasselbalch, Hans, Kusec, Rajko, Le Bousse-Kerdiles, Marie-Caroline, Liberato, Nicola L., Marchetti, Monia, Reilly, John T., Thiele, Jurgen

“…The European Myelofibrosis Network (EUMNET), a European research network on myelofibrosis with myeloid metaplasia (MMM), has developed a definition of response…”
Get full text

RBC-transfusion guidelines update by Gale, R.P, Barosi, G, Barbui, T, Cervantes, F, Dohner, K, Dupriez, B, Gupta, V, Harrison, C, Hoffman, R, Kiladjian, J.J, Mesa, R, Mc Mullin, M.F, Passamonti, F, Ribrag, V, Roboz, G, Saglio, G, Vannucchi, A, Verstovsek, S

Get full text

Elevated levels of basic fibroblast growth factor in megakaryocytes and platelets from patients with idiopathic myelofibrosis by MARTYRÉ, M.‐C., LE BOUSSE‐KERDILES, M.‐C., ROMQUIN, N., CHEVILLARD, S., PRALORAN, V., DEMORY, J.‐L., DUPRIEZ, B.

“…Idiopathic myelofibrosis, or agnogenic myeloid metaplasia, is a chronic myeloproliferative disorder characterized by clonal expansion and marrow fibrosis…”
Get full text

Role of splenectomy in the treatment of myelodysplastic syndromes with peripheral thrombocytopenia : a report on six cases by BOURGEOIS, E, CAULIER, M. T, ROSE, C, DUPRIEZ, B, BAUTERS, F, FENAUX, P

“…Thrombocytopenia is generally of central origin in MDS, but can be due to peripheral platelet destruction in some cases. We studied platelet lifespan in 61 MDS…”
Get full text

Transforming growth factor-beta and megakaryocytes in the pathogenesis of idiopathic myelofibrosis by Martyré, M C, Romquin, N, Le Bousse-Kerdiles, M C, Chevillard, S, Benyahia, B, Dupriez, B, Demory, J L, Bauters, F

“…Although the disease is well described, the pathogenesis of bone marrow fibrosis in idiopathic myelofibrosis still remains unclear. We previously reported…”
Get more information

Quinine improves the results of intensive chemotherapy in myelodysplastic syndromes expressing P glycoprotein: results of a randomized study by WATTEL, E, SOLARY, E, ROCHANT, H, CORDONNIER, C, DREYFUS, F, BUZYN, A, HOANG-NGOC, L, STOPPA, A. M, GRATECOS, N, SADOUN, A, STAMATOULAS, A, TILLY, H, HECQUET, B, BRICE, P, MALOISEL, F, LIOURE, B, DESABLENS, B, PIGNON, B, ABGRALL, J. P, LEPORRIER, M, DUPRIEZ, B, GUYOTAT, D, LEPELLEY, P, CAILLOT, D, FENAUX, P, IFRAH, N, BRION, A, MAHE, B, MILPIED, N, JANVIER, M, GUERCI, A

“…Intensive chemotherapy produces a lower complete remission (CR) rate in the myelodysplastic syndromes (MDS) than in de novo acute myeloid leukaemia (AML),…”
Get full text

A - 13 “Am I going to be like this forever?”: Athletes’ Experiences of Sport-Related Concussion Symptoms by CJ, Kennedy, M, Doucette, B, Dupriez-Mitchell, MA, Garcia-Barrera

“…Abstract Objective Previous research has focused on understanding the symptoms and long-term effects of sport-related concussion (SRC) through quantitative…”
Get full text

Prognosis and treatment of lymphoblastic lymphoma in adults: a report on 80 patients by Morel, P, Lepage, E, Brice, P, Dupriez, B, D'Agay, M F, Fenaux, P, Gosselin, B, Bauters, F, Gisselbrecht, C

“…We analyzed prognostic factors in 80 adult patients with lymphoblastic lymphoma (LBL). Twenty-one patients received six monthly courses of cyclophosphamide,…”
Get more information

The VIM3-AraC regimen followed by autologous stem cell transplantation in refractory or relapsing aggressive non-Hodgkin's lymphoma. A prospective study of 71 consecutive cases by PLANTIER-COLCHER, I, DUPRIEZ, B, SIMON, M, DETOURMIGNIES, JOUET, J. P, FENAUX, P, BAUTERS, F, MOREL, P

“…We evaluated with an intent-to-treat analysis the response rate, the disease-free survival (DFS), and the overall survival after a multidrug salvage regimen…”
Get full text

Cytogenetic studies and their prognostic significance in agnogenic myeloid metaplasia: a report on 47 cases by Demory, JL, Dupriez, B, Fenaux, P, Lai, JL, Beuscart, R, Jouet, JP, Deminatti, M, Bauters, F

“…Cytogenetic analysis was performed in 47 newly diagnosed patients with agnogenic myeloid metaplasia (AMM); 32 had a normal karyotype (68%, group I), whereas 15…”
Get full text

Intensive chemotherapy with thiotepa, busulfan and cyclophosphamide and hematopoietic stem cell rescue in relapsed or refractory primary central nervous system lymphoma and intraocular lymphoma: a retrospective study of 79 cases by SOUSSAIN, Carole, CHOQUET, Sylvain, HOUILLIER, Caroline, TAILLANDIER, Luc, HOANG-XUAN, Khe, LEBLOND, Véronique, FOURME, Emmanuelle, DELGADILLO, Daniel, BOUABDALLAH, Krimo, GHESQUIERES, Hervé, DAMAJ, Gandhi, DUPRIEZ, Brigitte, VARGAFTIG, Jacques, GONZALEZ, Alberto

“…Relapsing primary central nervous system lymphoma carries a poor prognosis when treated with conventional chemotherapy with a one-year overall survival of…”
Get full text

Autologous bone marrow transplantation as consolidation therapy may prolong remission in newly diagnosed high-risk follicular lymphoma: a pilot study of 34 cases by Morel, P, Laporte, J P, Noel, M P, Lopez, M, Douay, L, Fouillard, L, Detourmignies, L, Dupriez, B, Lesage, S, Isnard, F

“…We evaluated early intensification followed by autologous bone marrow transplantation (ABMT) using marrow purged by mafosfamide in patients with high-risk…”
Get more information

Aggressive lymphomas with renal involvement: a study of 48 patients treated with the LNH-84 and LNH-87 regimens by MOREL, P, DUPRIEZ, B, GISSELBRECHT, C, HERBRECHT, R, BASTION, Y, TILLY, H, DELANNOY, A, HAIOUN, C, NOUVEL, C, BOUABDALLAH, K, BAUMELOU, E

Get full text

ACVBP versus CHOP plus Radiotherapy for Localized Aggressive Lymphoma by Reyes, Félix, Lepage, Eric, Ganem, Gérard, Molina, Thierry J, Brice, Pauline, Coiffier, Bertrand, Morel, Pierre, Ferme, Christophe, Bosly, Andre, Lederlin, Pierre, Laurent, Guy, Tilly, Hervé

“…This large trial of the treatment of localized aggressive lymphoma in patients under the age of 60 years compared intensive chemotherapy with chemotherapy plus…”
Get full text

Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte by Haioun, C, Lepage, E, Gisselbrecht, C, Bastion, Y, Coiffier, B, Brice, P, Bosly, A, Dupriez, B, Nouvel, C, Tilly, H, Lederlin, P, Biron, P, Brière, J, Gaulard, P, Reyes, F

“…To update the randomized study that compared consolidative sequential treatment (ifosfamide, etoposide, asporaginase, and cytarabine) versus the high-dose…”
Get more information